Known for his work on chronic myeloid leukemia, Dr Ong Sin Tiong at Duke-NUS Medical School continues to shed light on the mechanisms of drug resistance in this hematologic cancer.
A team of scientists led by Nanyang Technological University, Singapore (NTU Singapore) has found that an existing cancer drug could be repurposed to ..
Existing cancer drug ponatinib could be repurposed to fight certain aggressive cancers medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.